Valor Management’s BioAge Labs BIOA Stock Holding History

Valor Management’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321K	Hold	13,105	–	–	﹤0.01%	5
2026 Q1	$229K	Hold	13,105	–	–	0.13%	5
2025 Q4	$173K	Hold	13,105	–	–	0.31%	3
2025 Q3	$77.1K	Hold	13,105	–	–	0.11%	4
2025 Q2	$54.1K	Hold	13,105	–	–	0.02%	4
2025 Q1	$49.3K	Hold	13,105	–	–	0.02%	4
2024 Q4	$75.9K	Hold	13,105	–	–	0.03%	4
2024 Q3	$273K	Buy	+13,105	New	+$263K	0.06%	4

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Topco New York $245B AUM

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Valor Management's BIOA Position: Q2 2026 in Review

Valor Management held its BioAge Labs (BIOA) position steady in Q2 2026 at 13,105 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #5.

Valor Management first reported a position in BIOA in Q3 2024 and has held it in 8 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

Valor Management held 13,105 shares of BioAge Labs worth $321K as of Q2 2026.
Valor Management left its BioAge Labs share count unchanged in Q2 2026.
BioAge Labs made up ﹤0.01% of Valor Management's portfolio in Q2 2026, its #5 holding.
Valor Management first reported a position in BioAge Labs in Q3 2024 and has held it in 8 quarters since.
150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Valor Management's 13F filing for Q2 2026, filed 14 Aug 2026.